期刊
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
卷 44, 期 7, 页码 613-618出版社
OXFORD UNIV PRESS
DOI: 10.1093/jjco/hyu054
关键词
breast cancer screening; mammography; net benefit; harm; ultrasonography
类别
资金
- 3rd term Comprehensive Control Research for Cancer, Ministry of Health, Labour and Welfare of Japan [H-18-Senryaku-001]
There have been controversies in breast cancer screening especially for women aged 40-49 years. Establishment of new evidence for breast cancer screening is needed in order to create a more effective screening system.Mammography is the only method of breast cancer screening that has established evidence of a mortality reduction. However, mammography does not achieve sufficient accuracy in the high-density breasts of patients < 50 years of age. In 2009, the US Preventive Services Task Force revised its recommendation for breast cancer screening in women aged 40-49 years from Grade B to C because the net benefit was relatively small for this age bracket. The net benefit of screening is the sum of benefits and harm and should always be monitored especially in population screening. A high recall rate, an inefficient number needed to invite for screening to prevent one breast cancer death, a high false-positive rate and unnecessary additional imaging for women aged 40-49 years are great concerns of mammography screening. Overdiagnosis is also a detriment of mammography screening; however, it may have a limited effect on women aged 40-49 years. Establishment of new evidence for breast cancer screening, such as ultrasonography screening, is needed in order to create a more effective screening system.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据